Cardiac Risks With Newer Psoriasis Meds Match TNF Inhibitors ...Middle East

Medscape - News
Cardiac Risks With Newer Psoriasis Meds Match TNF Inhibitors
A study of biologic-naive patients with psoriasis or PsA found that IL-17, IL-12/23, and IL-23 inhibitors have comparable cardiovascular and thrombotic risk profiles as TNF inhibitors. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Cardiac Risks With Newer Psoriasis Meds Match TNF Inhibitors )

Apple Storegoogle play

Also on site :



Latest News